Tennis elbow, also known as lateral epicondylitis, stands as the most frequent source of persistent pain along the outer aspect of the elbow, coupled with impaired function of the wrist extensor muscles. Common symptoms observed in lateral epicondylitis include reduced grip strength, limitations in performing daily tasks, and heightened pain levels, potentially leading to notable impairment in everyday activities. Traditional treatment modalities, including rest, physical therapy, NSAIDs, corticosteroid injections, and surgical intervention, have exhibited variable efficacy and are not devoid of limitations and risks. In recent years, regenerative medicine has emerged as a promising avenue for addressing the challenges posed by tennis elbow. Regenerative therapies harness the body's innate healing mechanisms to repair damaged tissues and facilitate tissue regeneration. These therapies encompass a diverse array of modalities, including platelet-rich plasma (PRP) injections, bone marrow aspirate concentrate, mesenchymal stem cell (MSC) therapy, and other biologic agents. This review article aims to provide a comprehensive overview of the current landscape of regenerative therapy for tennis elbow.
Yadav et al. (Mon,) studied this question.